Hayek Kallen Investment Management Abbott Laboratories Transaction History

Hayek Kallen Investment Management

$282 Million
Q3 2024

A detailed history of Hayek Kallen Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Hayek Kallen Investment Management holds 6,430 shares of ABT stock, worth $830,113. This represents 0.26% of its overall portfolio holdings.

Number of Shares

6,430

Previous 6,430 -0.0%

Holding current value

$830,113

Previous $668,000 9.73%

% of portfolio

0.26%

Previous 0.25%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$100.73 - $112.44 $5,036 - $5,622	-50 Reduced 0.77%	6,430 $668,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $10,078 - $11,229	-100 Reduced 1.52%	6,480 $706,000
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $33,271 - $39,032	-350 Reduced 5.05%	6,580 $722,000
Q3 2022 Oct 19, 2022	BUY	$96.76 - $112.03 $33,866 - $39,210	350 Added 5.32%	6,930 $671,000
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $15,310 - $18,505	-150 Reduced 2.23%	6,580 $715,000
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $5,701 - $6,952	-50 Reduced 0.74%	6,730 $797,000
Q3 2021 Oct 06, 2021	BUY	$116.66 - $129.06 $22,748 - $25,166	195 Added 2.96%	6,780 $801,000
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $5,289 - $6,226	-50 Reduced 0.75%	6,585 $763,000
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 1.48%	6,635 $722,000
Q2 2020 Sep 10, 2020	BUY	$76.57 - $98.0 $19,142 - $24,500	250 Added 3.86%	6,735 $616,000
Q1 2020 Apr 22, 2020	SELL	$62.82 - $91.86 $374,721 - $547,944	-5,965 Reduced 47.91%	6,485 $512,000
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $29,441 - $32,775	-375 Reduced 2.92%	12,450 $1.08 Million
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $9,820 - $10,648	-120 Reduced 0.93%	12,825 $1.07 Million
Q2 2019 Jul 17, 2019	SELL	$72.88 - $85.0 $3,644 - $4,250	-50 Reduced 0.38%	12,945 $1.09 Million
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $26,488 - $32,024	-400 Reduced 2.99%	12,995 $1.04 Million
Q4 2018 Jan 16, 2019	SELL	$65.56 - $74.27 $27,863 - $31,564	-425 Reduced 3.08%	13,395 $969,000
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $41,046 - $49,518	675 Added 4.62%	15,295 $916,000
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $89,694 - $108,206	-1,475 Reduced 9.64%	13,820 $1.01 Million
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $38,859 - $42,889	-675 Reduced 4.41%	14,620 $892,000
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $570,465 - $644,979	-10,138 Reduced 39.86%	15,295 $916,000
Q4 2017 Feb 08, 2018	SELL	$53.68 - $57.47 $10,736 - $11,494	-200 Reduced 0.78%	25,433 $1.45 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $1.23 Million - $1.37 Million	25,633	25,633 $1.37 Million

Others Institutions Holding ABT

# of Institutions

3,230

Shares Held

1.3B

Call Options Held

8.71M

Put Options Held

8.03M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hayek Kallen Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hayek Kallen Investment Management with notifications on news.

Account

Hayek Kallen Investment Management Abbott Laboratories Transaction History